Design
Review
Adiponectin assessment not indicated in clinical care; leaves open whether modulating levels improves vascular outcomes in obesity.
Adiponectin acts as an anti-inflammatory and anti-atherogenic plasma protein. Adiponectin is an endogenous biologically relevant modulator of vascular remodeling linking obesity and vascular disease.
No takes yet. Share an insight, caveat, or question.
Ouchi et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: